Drug Trial Radar · NCT04430790
Doxapram Therapy in Preterm Infants (DOXA Trial)
Last checked: Nov 20, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
396
Planned (sponsor's estimate)
Start
Jun 15, 2020
Primary completion
May 1, 2026
Study completion May 1, 2034
Sponsor
- Lead sponsor
- Erasmus Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Nederlands Neonataal Netwerk (N3), the Netherlands; Universitaire Ziekenhuizen KU Leuven; Maternal, Infant, Child and Youth Research Network (MICYRN)
- First posted
- Jun 12, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 23 weeks, up to 29 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Preterm infants often suffer from apnea of prematurity (AOP; a cessation of breathing) due to immaturity of the respiratory system. AOP can lead to oxygen shortage and a low heart rate which might harm the development of the newborn, especially the central nervous system. In order to prevent oxygen shortage, infants are treated with non-invasive respiratory support and caffeine. Despite these treatments, many preterm newborns still suffer from AOP and need invasive mechanical ventilation. Although this will result in complete resolution of AOP, invasive mechanical ventilation has the disadvantage of being a major risk of chronic lung disease and impaired neurodevelopmental outcome. Restrictive invasive ventilation is therefore advocated nowadays in preterm infants. Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term. This study compares doxapram to placebo and hypothesizes that doxapram will protect preterm infants from both invasive ventilation (and related lung disease) and AOP related oxygen shortage (and related impaired brain development).
Conditions
- Apnea of Prematurity
- Respiratory Insufficiency
Interventions
DoxapramDrug
Loading dose and continuous doxapram infusion.
PlaceboDrug
Loading dose and continuous placebo infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death or severe disabilityTime frame: 2 years corrected age
Locations
24 sites in 3 countries. Site status is shown where the registry gives one.
Sint Augustinus Hospital Antwerp
Antwerp, Belgium · Recruiting
University Hospital Antwerp
Antwerp, Belgium · Recruiting
Chirec-Delta Hospital
Brussels, Belgium · Recruiting
University Hospitals Leuven
Leuven, Belgium · Recruiting
St Luc Louvain
Brussels, Avenaue Hippocrate 10, Belgium · Recruiting
Delta Hospital Brussels
Brussels, Brussels Capital, Belgium · Recruiting
University Hospital Brussels
Jette, Brussels Capital, Belgium · Recruiting
Grand Hospital de Charleroi
Charleroi, Henegouwen, Belgium · Recruiting
Clinique Saint-Vincent Liege
Liège, Liege, Belgium · Suspended
Academisch Ziekenhuis Sint-Jan
Bruges, West-Vlaanderen, Belgium · Recruiting
Foothills Medical Centre
Calgary, Alberta, Canada · Not yet recruiting
Royal Alexandra Hospital
Edmonton, Alberta, Canada · Not yet recruiting
McMaster Children's Hospital
Hamilton, Ontario, Canada · Not yet recruiting
Montreal Children's Hospital
Montreal, Quebec, Canada · Not yet recruiting
Centre Mère-Enfent Soleil
Québec, Quebec, Canada · Not yet recruiting
University Medical Center Groningen
Groningen, Netherlands · Recruiting
UMC Utrecht - Wilhelmina Kinderziekenhuis
Utrecht, Netherlands · Recruiting
Radboudumc Amalia Children's Hospital Nijmegen
Nijmegen, Gelderland, Netherlands · Recruiting
Maastricht University Medical Center
Maastricht, Limburg, Netherlands · Recruiting
Maxima Medical Center Veldhoven
Veldhoven, North Brabant, Netherlands · Recruiting
Amsterdam University Medical Center
Amsterdam, North Holland, Netherlands · Recruiting
Isala Clinics Zwolle
Zwolle, Overijssel, Netherlands · Recruiting
Leiden University Medical Center
Leiden, South Holland, Netherlands · Recruiting
Erasmus Medical Center - Sophia Children's Hospital
Rotterdam, South Holland, Netherlands · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.